CTI BIOPHARMA CORP's ticker is CTIC and the CUSIP is 12648L601. A total of 92 filers reported holding CTI BIOPHARMA CORP in Q1 2022. The put-call ratio across all filers is 0.84 and the average weighting 0.3%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Stonepine Capital Management, LLC | 4,000,000 | $3,881,000 | 2.23% |
BVF INC/IL | 6,929,690 | $6,723,000 | 0.75% |
CAXTON CORP | 323,026 | $313,000 | 0.29% |
NEA Management Company, LLC | 3,750,000 | $3,638,000 | 0.19% |
Orbimed Advisors | 5,000,000 | $4,851,000 | 0.08% |
Fosun International Ltd | 300,428 | $288,000 | 0.02% |
OXFORD ASSET MANAGEMENT LLP | 105,385 | $102,000 | 0.00% |
A.R.T. Advisors, LLC | 30,055 | $29,000 | 0.00% |
Renaissance Technologies | 1,282,352 | $1,244,000 | 0.00% |
WASHINGTON TRUST Co | 16,000 | $15,000 | 0.00% |